Annika Kim Constantino highlights President Trump's new executive order targeting U.S. prescription drug prices through a "most favored nation" policy. Unlike previous efforts, this broad approach aims to align costs with lower prices from other countries, but raises concerns about profitability and innovation in the pharmaceutical industry. Critics warn of potential legal battles and adverse market effects. Explore the details in the full article: https://www.cnbc.com/2025/05/12/trump-drug-pricing-order-most-favored-nation.html #DrugPricing #PharmaceuticalIndustry #TrumpAdministration #HealthcarePolicy #PrescriptionDrugs #MostFavoredNation